Opendata, web and dolomites

ICA-100

A NOVEL NON-INVASIVE SOLUTION FOR CONTINUOUS BLOOD PRESSURE MONITORING

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ICA-100 project word cloud

Explore the words cloud of the ICA-100 project. It provides you a very rough idea of what is the project "ICA-100" about.

periodic    tracking    limited    critical    undertaken    systolic    deployment    granting    massive    read    hypo    complications    patents    framework    besides    performance    solution    financial    units    gold    continuous    serious    healthy    trl5    marketing    regulatory    attempts    pressure    strategy    solutions    catheter    unstable    diastolic    ing    obstacles    market    hemodynamically    patients    purpose    limitations    monitor    patient    plan    frame    ica    poses    icaria    tension    validated    regarding    freedom    relative    hyper    regarded    completing    individuals    sphygmomanometers    standard    accuracy    icu    poor    3b    positive    invasive    episodes    commercialise    certified    hospital    655m    risks    recalibrations    decades    capability    blood    device    accurate    obtaining    monitoring    hypertensive    hitherto    simplicity    none    influence    effect    follow    despite    operate    international    movements    protected    volunteers    technique    line    severe    obvious    mercury    intensive    arterial    feasibility    thoroughly    care    frequent   

Project "ICA-100" data sheet

The following table provides information about the project.

Coordinator
ICARIA MEDICAL S.L. 

Organization address
address: PZ PAU VILA, 1 PLANTA 2, PUERTA 2C EDIFICI PALAU DE MAR 2C
city: BARCELONA
postcode: 8039
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Project website https://www.icariamed.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-06-01   to  2019-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ICARIA MEDICAL S.L. ES (BARCELONA) coordinator 50˙000.00

Map

 Project objective

Blood pressure follow-up is essential in managing hemodynamically unstable patients at Intensive Care Units (ICU). Traditionally, mercury sphygmomanometers have been used for this purpose, and are regarded as the gold standard for Blood Pressure measurement. Despite the relative simplicity of the technique, sphygmomanometers have obvious limitations regarding accuracy and tracking capability, especially crucial for hospital patients. In the most critical patients the invasive arterial line catheter must be used, which however poses serious risks for severe complications. Over the past decades, several attempts have been undertaken to develop an effective, accurate and reliable solutions to continuously monitor blood pressure in a non-invasive way. Hitherto, none of the solutions under development have achieved a massive market deployment. Major obstacles for the implementation of state-of-the-art solutions are related to their limited performance, resulting in poor accuracy in hypo/hyper tension episodes, influence of patient movements on the system response, and need for periodic and frequent recalibrations. ICARIA has developed a solution for blood pressure monitoring (ICA-100) based on a novel operating principle that allows obtaining an accurate diastolic and systolic Blood Pressure read-out. The ICA-100 has already been validated in healthy volunteers (TRL5). The technology is protected by two international patents, granting ICARIA freedom-to-operate. In the frame of this Phase 1 Project we aim to further develop our marketing strategy and financial plan. Besides, we aim to assess thoroughly the relevant regulatory and legal framework for the Project. After completing this feasibility study, we plan to develop and commercialise a certified device for Continuous Non-Invasive Blood Pressure monitoring. Having a positive impact in 655m hospital patients and a potential favourable effect on 1.3b hypertensive individuals, from which only 1 in 5 is under control.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ICA-100" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ICA-100" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

DNA DS (2019)

DNA Data storage

Read More  

ERGOVIAkinematix (2018)

New wearable measurement devices for Industry 4.0 based on gaming motion-capture system

Read More  

Magnesys (2019)

Efficient filtering of metallic impurities in food processing

Read More